3. BEB
• Idiopathic focal dystonia
• Involuntary intermittent bilateral eyelid closure
• Women are affected more than men
• Usually begins in the 4th -6th decade of life
11. Botulinum toxin A for BEB
(FDA approved 1989)
(FDA approved 1989)
• Advise Risk & Benefit
• No contraindication for Botulinum toxin A injection
Neuromuscular disorder, Pregnancy-Lactation, Drug interaction
• May stop ASA 7 days (cosmetic issue)
• Cold pack for 5-10 mins (relieve pain & stop bleeding)
12. Potential adverse effects
• Effect of the toxin on adjacent non-target muscles
• Injection technique
• Mild & transient effects
14. Site of injection for BEB
- Orbicularis oculi (pretarsal part)
* subcutaneous injection
* medial & lateral area
* 2.5-5.0 unit (upper)
* 5.0-10.0 unit (lower)
- Corrugator & Procerus
* intramuscular injection
* 2.5-5.0 unit
15. Failure of botulinum toxin
• Inability of botulinum toxin to relieve squeezing
• Problem of eyelid opening
- Apraxia of eyelid opening (50%)
- Dermatochalasis, Brow ptosis
16. Apraxia of eyelid opening
• Inability to raise upper eyelid
• Often occur with BEB
• No eyelid squeezing , Elevation of eyebrow
• Botulinum toxin + upper myectomy + tightening levator M.
18. Hemifacial spasm
• Unilateral
• Dystonia of facial muscles
- Orbicularis oculi (precedes)
- Zygomaticus major
- Risorius
- Mentalis
• Normal ocular surface , Persist while sleeping
19. Hemifacial spasm
• The whole face on one side contracts
• Eyelid closure
• Elevation of corner of mouth
20. Etiology
• Hyperexcitability of the facial motor nucleus
- Idiopathic
- Ischemia or mass in pons (1%)
• Compression of the facial nerve near its exit from the
brainstem
- Tortuous AICA
- Dolichoectatic artery of the posterior circulation
23. Neuroimaging
• Brain MRI (เน้น brainstem) + MRA with/without GAD
• ตามตำาราแนะนำาให้ส่งทุก case
• ใน clinical practice จริงๆ มีหลากหลาย
- บางที่ส่งทุก case
- เลือกส่งในบาง case
มี neurological deficits อืนร่วม ไม่ตอบสนองต่อการรักษา
่
24. Management HFS
• Oral medications (same as for BEB)
• Chemodenervation with Botulinum toxin A
Duration of action tends to be longer than in BEB
• Microvascular decompression (craniotomy)
28. How to decrease the adverse
effect ?
• Small dosage for Zygomaticus Major
• Avoid Orbicularis Oris
• Inject Botulinum toxin at Depressor Anguli Oris
(DAO) or contralateral Zygomaticus major
• Lower dose if secondary to facial palsy
29. Take home message
• BEB is often a chronic progressive condition
• Beware of other causes of treatment failure with botulinum toxin
• Keep brain MRI in mind for HFS
• Counselling is important before treatment